【24h】

The role of hong kong sar in the development of biotechnology industry in China

机译:香港特区在中国生物技术产业发展中的作用

获取原文

摘要

The biotechnology industry is one of the fastest growing industries in China and, with a market size of l.2 billion consumers, the potential for its growth is enormous. With a vast network of state-supported academic and research institutions and a large number of scientists trained in topnotch universities worldwide, China also has a superior R&D infrastructure to support the discovery of biotechnology products. Nevertheless. for China's biotechnology industry to be globally competitive, it needs to upgrade its product development processes for the purpose of enabling its products to obtain registration approvals worldwide and be more cost-effective. Specifically, issues such as quality assurance, compliance to regulatory requirements, cost of goods and effective management must be addressed and resolved. In this regards, the Hong Kong Special Administrative Region (HKSAR) is poised to play a significant role in the development of biotechnology industry in China.
机译:生物技术行业是中国增长最快的行业之一,而市场规模为20亿消费者,其增长的潜力是巨大的。通过庞大的国家支持的学术和研究机构和大量的科学家,在全球范围内接受过Topnotch大学培训的大量科学家,中国也有一个优越的研发基础设施,以支持生物技术产品的发现。尽管如此。对于中国的生物技术行业具有全球竞争力,它需要升级其产品开发流程,以便使其产品能够在全球范围内获得注册批准并更具成本效益。具体而言,必须解决和解决质量保证,遵守法规要求,货物成本和有效管理的问题。在这方面,香港特别行政区(香港特区)致力于在中国生物技术行业的发展中发挥着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号